Mammalian Target of Rapamycin Inhibitors Against Hepatocellular Carcinoma Recurrence After Liver Transplantation.
14th Department of Internal Medicine, Medical School of Aristotle University, Hippokration General Hospital of Thessaloniki, Greece.
Evangelos
E
Cholongitas
D006528:Carcinoma, Hepatocellular; D006801:Humans; D008113:Liver Neoplasms; D016031:Liver Transplantation; D009364:Neoplasm Recurrence, Local; D020123:Sirolimus
D020123:Sirolimus